Science Explorer Back to mapMap
Discussion
Topic · Pharmacology

Antibiotics Pharmacokinetics and Efficacy

Antibiotics Pharmacokinetics and Efficacy is a research topic within Pharmacology. Science Explorer counts 50k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pharmacokinetics of antibiotics, particularly in critically ill patients. It covers topics such as drug dosing, antimicrobial resistance, therapeutic drug monitoring, and the impact of factors like augmented renal clearance on antibiotic levels in the body.

  • Antibiotic Pharmacokinetics
  • Critically Ill Patients
  • Pharmacodynamic
  • Beta-lactam Antibiotics
  • Drug Dosing
  • Antimicrobial Resistance
  • Continuous Infusion
  • Aminoglycosides
  • Therapeutic Drug Monitoring
  • Augmented Renal Clearance
Research works
50k
fractional, since 1950
In the world top 10%
4.9k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+4%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now
Antibiotics Pharmacokinetics and Efficacy

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Antibiotics Pharmacokinetics and Efficacy research?

By volume, the United States and China publish the most (1.3k and 1.1k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.3k works
  2. 2 China 1.1k works
  3. 3 India 601 works
  4. 4 France 259 works
  5. 5 Egypt 245 works
  6. 6 Spain 244 works
  7. 7 Japan 242 works
  8. 8 Italy 227 works
  9. 9 United Kingdom 216 works
  10. 10 Türkiye 188 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 27.9%China: 24.4%India: 12.9%France: 5.6%6 others listed: 29.3%28%largest
United States1,299 · 27.9%China1,138 · 24.4%India601 · 12.9%France259 · 5.6%6 others listed1,363 · 29.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Antibiotics Pharmacokinetics and Efficacy research?

By volume in 2022-now, Zhejiang University publishes the most Antibiotics Pharmacokinetics and Efficacy research, followed by Fudan University and Inserm.

By volume, 2022-now

  1. 1 Zhejiang UniversityChina 39 works
  2. 2 Fudan UniversityChina 37 works
  3. 3 InsermFrance 35 works
  4. 4 Cairo UniversityEgypt 32 works
  5. 5 The University of QueenslandAustralia 27 works
  6. 6 JMI LaboratoriesUnited States 26 works
  7. 7 Centre National de la Recherche ScientifiqueFrance 25 works
  8. 8 King Saud UniversitySaudi Arabia 25 works
  9. 9 University of North Carolina at Chapel HillUnited States 24 works
  10. 10 Sichuan UniversityChina 23 works

Who are the leading researchers in Antibiotics Pharmacokinetics and Efficacy?

The most-cited researchers publishing on Antibiotics Pharmacokinetics and Efficacy include George Davey Smith, Bert Vogelstein and Zulfiqar Ahmed Bhutta.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Bert Vogelstein United States 373k citations
  3. 3 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  4. 4 Giuseppe Remuzzi Italy 328k citations
  5. 5 Matthias Egger Switzerland 326k citations
  6. 6 Dan J. Stein South Africa 306k citations
  7. 7 Salim Yusuf Canada 294k citations
  8. 8 Jeremy Grimshaw Canada 281k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Antibiotics Pharmacokinetics and Efficacy?

The most cited paper in Antibiotics Pharmacokinetics and Efficacy is "Antibiotic resistance—the need for global solutions" (Ramanan Laxminarayan et al., 2013), with 4,516 citations. Next come "Antibiotics in the aquatic environment – A review – Part I" (4,483) and "Determination of minimum inhibitory concentrations" (4,142).

Most cited papers
#PaperReleasedCitations
1 Antibiotic resistance—the need for global solutions Ramanan Laxminarayan et al. · The Lancet Infectious Diseases Open access 16 Nov 2013 4,516
2 Antibiotics in the aquatic environment – A review – Part I Klaus Kümmerer · Chemosphere 31 Jan 2009 4,483
3 Determination of minimum inhibitory concentrations Jennifer M. Andrews · Journal of Antimicrobial Chemotherapy Open access Jul 2001 4,142
4 Extended-Spectrum β-Lactamases: a Clinical Update David L. Paterson, Robert A. Bonomo · Clinical Microbiology Reviews Open access Oct 2005 3,505
5 Occurrence of drugs in German sewage treatment plants and rivers Thomas A. Ternes · Water Research Nov 1998 3,419
All 100 most cited papers, with filters and sorting

Where is Antibiotics Pharmacokinetics and Efficacy research done?

The largest centres of Antibiotics Pharmacokinetics and Efficacy research in 2022-now are Beijing (China), Shanghai (China), Paris (France) and Hangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in North Liberty, Visakhapatnam and Al Mansurah.

Largest cities, 2022-now

  1. 1 BeijingChina 162 works
  2. 2 ShanghaiChina 92 works
  3. 3 ParisFrance 87 works
  4. 4 HangzhouChina 78 works
  5. 5 TokyoJapan 72 works
  6. 6 MadridSpain 65 works
  7. 7 LondonUnited Kingdom 64 works
  8. 8 CairoEgypt 62 works
  9. 9 GuangzhouChina 59 works
  10. 10 NanjingChina 56 works

Where it is the local speciality

  1. North LibertyUS · 25.9 works454×
  2. VisakhapatnamIN · 25.3 works9.4×
  3. Al MansurahEG · 27.6 works8.1×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Antibiotics Pharmacokinetics and Efficacy than the world average.

See Antibiotics Pharmacokinetics and Efficacy on the map

Where is the best place to study Antibiotics Pharmacokinetics and Efficacy?

Among universities, judged by research, Zhejiang University, University of Bologna and Fudan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.39%fractional works in this field (log) →share of work in the world top 10% →Zhejiang UniversityUniversity of BolognaThe University of Qu…Fudan University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Zhejiang UniversityChina 84.221.4%2.4×39 +31.1%
2University of BolognaItaly 74.521.3%4.0×20 +54.6%
3Fudan UniversityChina 71.913.2%3.8×37 +94.9%
4The University of QueenslandAustralia 69.915.7%4.7×27 -37.1%
5Johns Hopkins UniversityUnited States 68.420.1%2.1×20 -10.4%
6King Saud UniversitySaudi Arabia 64.211.5%4.1×25 +31.8%
7University of TurinItaly 61.121.6%3.5×12 +59.9%
8Uppsala UniversitySweden 60.714.7%4.1×14 +3.7%
9Mansoura UniversityEgypt 60.513.2%8.0×22 +16.0%
10Erasmus University RotterdamNetherlands 60.011.2%5.4×17 -5.6%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Antibiotics Pharmacokinetics and Efficacy, country by country

Is Antibiotics Pharmacokinetics and Efficacy research growing?

Output in 2022-2025 was 4% higher than in 2018-2021, peaking in 2023. The fastest-growing topics are Antibiotics Pharmacokinetics and Efficacy.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Antibiotics Pharmacokinetics and Efficacy as a percentage of every work published that year, 0.028% in 2024.

still counting0.050%0.10%0.15%Antibiotics Pharmacokinetics and Efficacy0.027% in 202519801990200020102020

Fractional works of Antibiotics Pharmacokinetics and Efficacy over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Antibiotics Pharmacokinetics and Efficacy10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Antibiotics Pharmacokinetics and Efficacy. Posts are plain text and can be reported.